Cargando…
_version_ 1785090610402689024
author von Glasenapp, Alana
Uriol, Denisse Castro
Garate, Brady Beltran
Paredes, Sally
Otero, Victoria
Rivarola, Sofia
Alvarado, César Camilo Carías
Menéndez, Juan Carlos Barrios
Oliver, Carolina
Irigoin, Victoria
Aguia, Julio Fernández
Valvert, Fabiola
Quintero, Henry Idrobo
Pascuaza, Yudy Lorena Delgado
Mingan, Gloria Caterine Peréz
Martinez, Humberto
Valcarcel, Bryan
Malpica, Luis
author_facet von Glasenapp, Alana
Uriol, Denisse Castro
Garate, Brady Beltran
Paredes, Sally
Otero, Victoria
Rivarola, Sofia
Alvarado, César Camilo Carías
Menéndez, Juan Carlos Barrios
Oliver, Carolina
Irigoin, Victoria
Aguia, Julio Fernández
Valvert, Fabiola
Quintero, Henry Idrobo
Pascuaza, Yudy Lorena Delgado
Mingan, Gloria Caterine Peréz
Martinez, Humberto
Valcarcel, Bryan
Malpica, Luis
author_sort von Glasenapp, Alana
collection PubMed
description
format Online
Article
Text
id pubmed-10429017
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104290172023-08-17 PB2264: CLINICAL FEATURES, TREATMENT PATTERNS, AND OUTCOMES AMONG 120 PATIENTS WITH MALT LYMPHOMA IN LATIN AMERICA: A STUDY FROM THE GRUPO DE ESTUDIO LATINOAMERICANO DE LINFOPROLIFERATIVOS (GELL) von Glasenapp, Alana Uriol, Denisse Castro Garate, Brady Beltran Paredes, Sally Otero, Victoria Rivarola, Sofia Alvarado, César Camilo Carías Menéndez, Juan Carlos Barrios Oliver, Carolina Irigoin, Victoria Aguia, Julio Fernández Valvert, Fabiola Quintero, Henry Idrobo Pascuaza, Yudy Lorena Delgado Mingan, Gloria Caterine Peréz Martinez, Humberto Valcarcel, Bryan Malpica, Luis Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429017/ http://dx.doi.org/10.1097/01.HS9.0000975788.44285.91 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Publication Only
von Glasenapp, Alana
Uriol, Denisse Castro
Garate, Brady Beltran
Paredes, Sally
Otero, Victoria
Rivarola, Sofia
Alvarado, César Camilo Carías
Menéndez, Juan Carlos Barrios
Oliver, Carolina
Irigoin, Victoria
Aguia, Julio Fernández
Valvert, Fabiola
Quintero, Henry Idrobo
Pascuaza, Yudy Lorena Delgado
Mingan, Gloria Caterine Peréz
Martinez, Humberto
Valcarcel, Bryan
Malpica, Luis
PB2264: CLINICAL FEATURES, TREATMENT PATTERNS, AND OUTCOMES AMONG 120 PATIENTS WITH MALT LYMPHOMA IN LATIN AMERICA: A STUDY FROM THE GRUPO DE ESTUDIO LATINOAMERICANO DE LINFOPROLIFERATIVOS (GELL)
title PB2264: CLINICAL FEATURES, TREATMENT PATTERNS, AND OUTCOMES AMONG 120 PATIENTS WITH MALT LYMPHOMA IN LATIN AMERICA: A STUDY FROM THE GRUPO DE ESTUDIO LATINOAMERICANO DE LINFOPROLIFERATIVOS (GELL)
title_full PB2264: CLINICAL FEATURES, TREATMENT PATTERNS, AND OUTCOMES AMONG 120 PATIENTS WITH MALT LYMPHOMA IN LATIN AMERICA: A STUDY FROM THE GRUPO DE ESTUDIO LATINOAMERICANO DE LINFOPROLIFERATIVOS (GELL)
title_fullStr PB2264: CLINICAL FEATURES, TREATMENT PATTERNS, AND OUTCOMES AMONG 120 PATIENTS WITH MALT LYMPHOMA IN LATIN AMERICA: A STUDY FROM THE GRUPO DE ESTUDIO LATINOAMERICANO DE LINFOPROLIFERATIVOS (GELL)
title_full_unstemmed PB2264: CLINICAL FEATURES, TREATMENT PATTERNS, AND OUTCOMES AMONG 120 PATIENTS WITH MALT LYMPHOMA IN LATIN AMERICA: A STUDY FROM THE GRUPO DE ESTUDIO LATINOAMERICANO DE LINFOPROLIFERATIVOS (GELL)
title_short PB2264: CLINICAL FEATURES, TREATMENT PATTERNS, AND OUTCOMES AMONG 120 PATIENTS WITH MALT LYMPHOMA IN LATIN AMERICA: A STUDY FROM THE GRUPO DE ESTUDIO LATINOAMERICANO DE LINFOPROLIFERATIVOS (GELL)
title_sort pb2264: clinical features, treatment patterns, and outcomes among 120 patients with malt lymphoma in latin america: a study from the grupo de estudio latinoamericano de linfoproliferativos (gell)
topic Publication Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429017/
http://dx.doi.org/10.1097/01.HS9.0000975788.44285.91
work_keys_str_mv AT vonglasenappalana pb2264clinicalfeaturestreatmentpatternsandoutcomesamong120patientswithmaltlymphomainlatinamericaastudyfromthegrupodeestudiolatinoamericanodelinfoproliferativosgell
AT urioldenissecastro pb2264clinicalfeaturestreatmentpatternsandoutcomesamong120patientswithmaltlymphomainlatinamericaastudyfromthegrupodeestudiolatinoamericanodelinfoproliferativosgell
AT garatebradybeltran pb2264clinicalfeaturestreatmentpatternsandoutcomesamong120patientswithmaltlymphomainlatinamericaastudyfromthegrupodeestudiolatinoamericanodelinfoproliferativosgell
AT paredessally pb2264clinicalfeaturestreatmentpatternsandoutcomesamong120patientswithmaltlymphomainlatinamericaastudyfromthegrupodeestudiolatinoamericanodelinfoproliferativosgell
AT oterovictoria pb2264clinicalfeaturestreatmentpatternsandoutcomesamong120patientswithmaltlymphomainlatinamericaastudyfromthegrupodeestudiolatinoamericanodelinfoproliferativosgell
AT rivarolasofia pb2264clinicalfeaturestreatmentpatternsandoutcomesamong120patientswithmaltlymphomainlatinamericaastudyfromthegrupodeestudiolatinoamericanodelinfoproliferativosgell
AT alvaradocesarcamilocarias pb2264clinicalfeaturestreatmentpatternsandoutcomesamong120patientswithmaltlymphomainlatinamericaastudyfromthegrupodeestudiolatinoamericanodelinfoproliferativosgell
AT menendezjuancarlosbarrios pb2264clinicalfeaturestreatmentpatternsandoutcomesamong120patientswithmaltlymphomainlatinamericaastudyfromthegrupodeestudiolatinoamericanodelinfoproliferativosgell
AT olivercarolina pb2264clinicalfeaturestreatmentpatternsandoutcomesamong120patientswithmaltlymphomainlatinamericaastudyfromthegrupodeestudiolatinoamericanodelinfoproliferativosgell
AT irigoinvictoria pb2264clinicalfeaturestreatmentpatternsandoutcomesamong120patientswithmaltlymphomainlatinamericaastudyfromthegrupodeestudiolatinoamericanodelinfoproliferativosgell
AT aguiajuliofernandez pb2264clinicalfeaturestreatmentpatternsandoutcomesamong120patientswithmaltlymphomainlatinamericaastudyfromthegrupodeestudiolatinoamericanodelinfoproliferativosgell
AT valvertfabiola pb2264clinicalfeaturestreatmentpatternsandoutcomesamong120patientswithmaltlymphomainlatinamericaastudyfromthegrupodeestudiolatinoamericanodelinfoproliferativosgell
AT quinterohenryidrobo pb2264clinicalfeaturestreatmentpatternsandoutcomesamong120patientswithmaltlymphomainlatinamericaastudyfromthegrupodeestudiolatinoamericanodelinfoproliferativosgell
AT pascuazayudylorenadelgado pb2264clinicalfeaturestreatmentpatternsandoutcomesamong120patientswithmaltlymphomainlatinamericaastudyfromthegrupodeestudiolatinoamericanodelinfoproliferativosgell
AT mingangloriacaterineperez pb2264clinicalfeaturestreatmentpatternsandoutcomesamong120patientswithmaltlymphomainlatinamericaastudyfromthegrupodeestudiolatinoamericanodelinfoproliferativosgell
AT martinezhumberto pb2264clinicalfeaturestreatmentpatternsandoutcomesamong120patientswithmaltlymphomainlatinamericaastudyfromthegrupodeestudiolatinoamericanodelinfoproliferativosgell
AT valcarcelbryan pb2264clinicalfeaturestreatmentpatternsandoutcomesamong120patientswithmaltlymphomainlatinamericaastudyfromthegrupodeestudiolatinoamericanodelinfoproliferativosgell
AT malpicaluis pb2264clinicalfeaturestreatmentpatternsandoutcomesamong120patientswithmaltlymphomainlatinamericaastudyfromthegrupodeestudiolatinoamericanodelinfoproliferativosgell